Institut du Vieillissement, Gérontopôle de Toulouse, Centre Hospitalo-Universitaire de Toulouse, Toulouse, France.
LiMitAging, Institut des Maladies Métaboliques et Cardiovasculaires, I2MC, Université de Toulouse, INSERM, Université Toulouse III - Paul Sabatier (UPS), Toulouse, France.
J Gerontol A Biol Sci Med Sci. 2024 Jan 1;79(1). doi: 10.1093/gerona/glad142.
Intrinsic capacity (IC) is a concept related to functionality that reflects healthy aging. ATPase inhibitory factor 1 (IF1) is a multifaceted protein that regulates mitochondrial oxidative phosphorylation (OXPHOS), and may be involved in IC. The objective of this study is to investigate the association between plasma levels of IF1 and IC changes in community-dwelling older adults.
Community-dwelling older adults from the Multidomain Alzheimer Preventive Trial (MAPT Study) were enrolled in this study. A composite IC score was calculated based on 4 IC domains: locomotion, psychological dimension, cognition, and vitality (with data available annually over 4 years of follow-up). Secondary analyses were conducted on the sensory domain (with data available only for 1 year of follow-up). Mixed-model linear regression adjusted for confounders was conducted.
A total of 1 090 participants with usable IF1 values were included in the study (75.3 ± 4.4 years; 64% females). Compared to the lowest quartile, both the low- and high-intermediate IF1 quartiles were found to be cross-sectionally associated with greater composite IC scores across 4 domains (βlow-intermediate, 1.33; 95% confidence interval [CI] 0.06-2.60 and βhigh-intermediate, 1.78; 95% CI 0.49-3.06). In the secondary analyses, the highest quartile was found to be associated with a slower decline in composite IC scores across 5 domains over 1 year (βhigh 1.60; 95% CI 0.06-3.15). The low- and high-intermediate IF1 quartiles were also found to be cross-sectionally associated with greater locomotion (βlow-intermediate, 2.72; 95% CI 0.36-5.08) and vitality scores (βhigh-intermediate, 1.59; 95% CI 0.06-3.12), respectively.
This study is the first to demonstrate that levels of circulating IF1, a mitochondrial-related biomarker, are associated with IC composite scores in both cross-sectional and prospective analyses among community-dwelling older adults. However, further research is needed to confirm these findings and elucidate the potential underlying mechanisms that may explain these associations.
内在能力(IC)是一个与功能相关的概念,反映了健康衰老。三磷酸腺苷酶抑制因子 1(IF1)是一种多方面的蛋白质,可调节线粒体氧化磷酸化(OXPHOS),并可能与 IC 有关。本研究的目的是探讨社区居住的老年人血浆 IF1 水平与 IC 变化之间的关系。
该研究纳入了来自多领域阿尔茨海默病预防试验(MAPT 研究)的社区居住的老年人。根据 4 个 IC 域计算了一个综合 IC 评分:运动能力、心理维度、认知和活力(在 4 年的随访中每年提供数据)。对感觉域进行了二次分析(仅在 1 年的随访中提供数据)。进行了调整混杂因素的混合模型线性回归。
共纳入了 1090 名具有可用 IF1 值的参与者(75.3±4.4 岁;64%为女性)。与最低四分位数相比,低中和高 IF1 四分位数在 4 个领域的综合 IC 评分上均表现出横断面关联(低-中 IF1 四分位数,1.33;95%置信区间 [CI] 0.06-2.60;高-中 IF1 四分位数,1.78;95%CI 0.49-3.06)。在二次分析中,发现最高四分位数与 1 年内 5 个领域的综合 IC 评分下降速度较慢有关(高四分位数β1.60;95%CI 0.06-3.15)。低和高 IF1 四分位数在横断面上也与更大的运动能力(β低-中 IF1 四分位数 2.72;95%CI 0.36-5.08)和活力评分(β高-中 IF1 四分位数 1.59;95%CI 0.06-3.12)相关。
这项研究首次表明,循环 IF1(一种与线粒体相关的生物标志物)的水平与社区居住的老年人的综合 IC 评分在横断面和前瞻性分析中均相关。但是,需要进一步的研究来证实这些发现并阐明可能解释这些关联的潜在机制。